Medicenna Therapeutics appointed Dr. Nageatte Ibrahim as Chief Medical Officer. The hire is a routine senior-management update intended to bolster the company’s clinical leadership and has limited immediate market or financial impact.
Medicenna Therapeutics appointed Dr. Nageatte Ibrahim as Chief Medical Officer. The hire is a routine senior-management update intended to bolster the company’s clinical leadership and has limited immediate market or financial impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.05
